切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (01) : 41 -45. doi: 10.3877/cma.j.issn.2095-3232.2014.01.011

所属专题: 文献

基础研究

人肝癌干细胞生物学行为的实验研究
姜楠1,(), 阮丹云2, 李洋1, 汪国营1, 傅斌生1, 汪根树1, 李华1, 张剑1, 杨扬1, 陈规划1   
  1. 1. 510630 广州,中山大学附属第三医院肝移植中心 中山大学器官移植研究所 广东省器官移植研究中心
    2. 510630 广州,中山大学附属第三医院肿瘤内科
  • 收稿日期:2013-11-16 出版日期:2014-02-10
  • 通信作者: 姜楠
  • 基金资助:
    国家重点基础研究发展计划(973计划)(2009CB522404); 国家十二五科技重大专项(2012ZX10002017-005); 国家自然科学基金(81000959); 中央高校基本业务费青年教师培育项目(12ykpy47,12ykpy43); 广东省科技计划项目(2009B030801007)

Experimental research on the biological behavior of human liver cancer stem cells

Nan Jiang1,(), Danyun Ruan2, Yang Li1, Guoying Wang1, Binsheng Fu1, Genshu Wang1, Hua Li1, Jian Zhang1, Yang Yang1, Guihua Chen1   

  1. 1. Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Institute of Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou 510630, China
  • Received:2013-11-16 Published:2014-02-10
  • Corresponding author: Nan Jiang
  • About author:
    Corresponding auther: Jiang Nan, Email:
引用本文:

姜楠, 阮丹云, 李洋, 汪国营, 傅斌生, 汪根树, 李华, 张剑, 杨扬, 陈规划. 人肝癌干细胞生物学行为的实验研究[J/OL]. 中华肝脏外科手术学电子杂志, 2014, 03(01): 41-45.

Nan Jiang, Danyun Ruan, Yang Li, Guoying Wang, Binsheng Fu, Genshu Wang, Hua Li, Jian Zhang, Yang Yang, Guihua Chen. Experimental research on the biological behavior of human liver cancer stem cells[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(01): 41-45.

目的

探讨人肝癌干细胞的生物学行为。

方法

取对数生长期的人肝癌MHCC97H细胞接种至无血清培养基悬浮培养,获得稳定传代的人肝癌MHCC97H干细胞。分别取人肝癌MHCC97H干细胞微球和人肝癌MHCC97H细胞,应用逆转录聚合酶链反应(RT-PCR)检测细胞标志物分化群(CD)133、CD90、上皮细胞黏附分子(EpCAM)信使核糖核酸(mRNA)。分别进行克隆形成实验、肿瘤细胞侵袭实验(Transwell实验)、裸鼠成瘤实验观察两种细胞克隆形成、侵袭性及成瘤情况。两种细胞实验数据比较采用tt′检验。

结果

人肝癌MHCC97H干细胞CD133、CD90、EpCAM mRNA含量分别为32.70±0.20、66.30±0.32、115.40±4.00,人肝癌MHCC97H细胞分别为1.27±0.29、13.60±1.36、1.34±0.40,人肝癌MHCC97H干细胞CD133、CD90、EpCAM mRNA平均含量明显高于人肝癌MHCC97H细胞(t′=117.8, 53.97, 83.37; P<0.05)。人肝癌MHCC97H干细胞的克隆形成率为(213±10)%,人肝癌MHCC97H细胞为(54±11)%,差异有统计学意义(t=13.11, P<0.05)。通过Transwell实验发现,人肝癌MHCC97H干细胞穿膜细胞数为(587±120)个/视野,人肝癌MHCC97H细胞为(97±13)个/视野,差异有统计学意义(t=6.38, P<0.05)。在裸鼠成瘤实验中,接种2×103个人肝癌MHCC97H干细胞的裸鼠4周可形成皮下移植瘤,成瘤率1/6;2×105个人肝癌MHCC97H干细胞可使全部裸鼠形成皮下移植瘤,成瘤率6/6;至少需要2×105个人肝癌MHCC97H细胞裸鼠才能形成皮下移植瘤,成瘤率2/6。

结论

与人肝癌MHCC97H细胞相比,人肝癌MHCC97H干细胞具有更强的侵袭性和更高的成瘤率。

Objective

To study the biological behavior of human liver cancer stem cells.

Methods

Human liver cancer MHCC97H cells in logarithmic growth phase were inoculated in the serum free medium for suspension cultivation and human liver cancer MHCC97H stem cells with stable propagation were acquired. Human liver cancer MHCC97H stem cell microspheres and human liver cancer MHCC97H cells were collected. Messenger ribonucleic acid (mRNA) of cell markers including cluster of differentiation (CD) 133, CD90, epithelial cell adhesion molecule (EpCAM) was detected by reverse transcription polymerase chain reaction (RT-PCR). Colony formation assay, tumor cell invasion assay (Transwell assay) and nude mouse tumorigenicity assay were performed respectively to observe the colony formation, cell invasion and tumorigenicity of two kinds of cells. The experimental data of two kinds of cells were compared by t test or t′ test.

Results

The mean contents of CD133, CD90, EpCAM mRNA in human liver cancer MHCC97H stem cells (32.70±0.20, 66.30±0.32, 115.40±4.00) were significantly higher than those in human liver cancer MHCC97H cells (1.27±0.29, 13.60±1.36, 1.34±0.40) (t′=117.8, 53.97, 83.37; P<0.05). The colony forming efficiency was (213±10)% in human liver cancer MHCC97H stem cells and was (54±11)% in human liver cancer MHCC97H cells, where significant difference was observed (t=13.11, P<0.05). Through the Transwell assay, the membrane permeating cell count was (587±120) /visual fields in human liver cancer MHCC97H stem cells, and was (97±13) /visual fields in human liver cancer MHCC97H cells, where significant difference was observed (t=6.38, P<0.05). In the nude mouse tumorigenicity assay, subcutaneous transplanted tumors were observed in nude mouse 4 weeks after inoculating 2×103 human liver cancer MHCC97H stem cells and the tumor formation rate was 1/6. Subcutaneous transplanted tumors were observed in all nude mice by inoculating 2×105 human liver cancer MHCC97H stem cells, and the tumor formation rate was 6/6. Subcutaneous transplanted tumors were observed in nude mice by inoculating at least 2×105 human liver cancer MHCC97H cells, and the tumor formation rate was 2/6.

Conclusion

Compared with the human liver cancer MHCC97H cells, human liver cancer MHCC97H stem cells possess stronger invasion and higher tumor formation rate.

图1 无血清悬浮培养法培养7 d获得的人肝癌MHCC97H干细胞球(荧光显微镜×200)
图2 人肝癌MHCC97H干细胞和人肝癌MHCC97H细胞的Transwell实验结果(HE ×200)
[1]
Clarke MF,Dick JE,Dirks PB, et al. Cancer stem cells: perspectives on current status and future directionsAACR Workshop on cancer stem cells[J].. Cancer Res, 2006, 66(19): 9339-9344.
[2]
Reya T,Morrison SJ,Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001, 414(6859): 105-111.
[3]
Al-Hajj M,Wicha MS,Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci U S A, 2003, 100(7): 3983-3988.
[4]
Singh SK,Hawkins C,Clarke ID, et al. Identification of human brain tumour initiating cells[J]. Nature, 2004, 432(7015): 396-401.
[5]
Martens DJ,Tropepe V,van der Kooy D. Separate proliferation kinetics of fibroblast growth factor-responsive and epidermal growth factor-responsive neural stem cells within the embryonic forebrain germinal zone[J]. J Neurosci, 2000, 20(3): 1085-1095.
[6]
Singh SK,Clarke ID,Terasaki M, et al. Identification of a cancer stem cell in human brain tumors[J]. Cancer Res, 2003, 63(18): 5821-5828.
[7]
Ponti D,Costa A,Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties[J]. Cancer Res, 2005, 65(13): 5506-5511.
[8]
Hong-mei P,Gui-an C. Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines[J]. Hum Reprod, 2006, 21(1): 217-222.
[9]
Hemmati HD,Nakano I,Lazareff JA, et al. Cancerous stem cell can arise from pediatric brain tumors[J]. Proc Natl Acad Sci U S A, 2003, 100(25): 15178-15183.
[10]
Reynolds BA,Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell[J]. Dev Biol, 1996, 175(1): 1-13.
[11]
Haraguchi N,Utsunomiya T,Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system[J]. Stem Cells, 2006, 24(3): 506-513.
[12]
Yin S,Li J,Hu C, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity[J]. Int J Cancer, 2007, 120(7): 1444-1450.
[13]
Yang ZF,Ho DW,Ng MN, et al. Significance of CD90+ cancer stem cells in human liver cancer[J]. Cancer Cell, 2008, 13(2): 153-166.
[14]
Yamashita T,Ji J,Budhu A, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features[J]. Gastroenterology, 2009, 136(3): 1012-1024.
[1] 何甘霖, 陈香侬, 李萍, 甄佳怡, 李京霞, 邹外一, 许多荣. 白血病异基因造血干细胞移植术后股骨坏死的影响因素[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 450-456.
[2] 刘昌玲, 张金丽, 张志, 李孝建, 汤文彬, 胡逸萍, 陈宾, 谢晓娜. 负载人脂肪干细胞外泌体的甲基丙烯酰化明胶水凝胶对人皮肤成纤维细胞增殖和迁移的影响[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 517-525.
[3] 雷子威, 凌萍, 沈纵, 魏晨如, 朱邦晖, 伍国胜, 孙瑜. 类器官肺损伤疾病模型构建及应用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 531-535.
[4] 宋勤琴, 李双汝, 李林, 杜鹃, 刘继松. 间充质干细胞源性外泌体在改善病理性瘢痕中作用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 550-553.
[5] 关丁丁, 李伟, 孔维诗, 包郁露, 孙瑜. 负载干细胞的光交联蛋白基水凝胶在组织工程中应用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 447-452.
[6] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[7] 王大伟, 陆雅斐, 皇甫少华, 陈玉婷, 陈澳, 江滨. 间充质干细胞通过调控免疫机制促进创面愈合的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 361-366.
[8] 刘文竹, 唐窈, 刘付臣. 诱导多潜能干细胞在神经肌肉疾病研究中的应用进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 367-373.
[9] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[10] 蔡艺丹, 方坚, 张志强, 陈莉, 张世安, 夏磊, 阮梅, 李东良. 经颈静脉肝内门体分流术对肝硬化门脉高压患者肠道菌群及肝功能的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 285-293.
[11] 王俊楠, 刘晔, 李若涵, 叶青松. 间充质干细胞调控肠脑轴治疗神经系统疾病的潜力[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 313-319.
[12] 陈丽璇, 窦培宁, 肖扬. 干细胞治疗早发性卵巢功能不全的现状及未来展望[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 239-248.
[13] 杜鑫, 刘霞霞, 张恬波, 张夏林, 杨林花, 张睿娟. AHNAK基因高表达与老年急性髓系白血病患者预后不良相关[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 204-211.
[14] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[15] 汪鹏飞, 程莹莹, 赵海康. 骨髓间充质干细胞改善神经病理性疼痛的机制探讨[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 230-234.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?